Since Leqembi is dosed based on a patient’s weight and offered in single-use vials, about 5.8% of the drug dispensed will be ...
A simple tweak in available vial sizes of the breakthrough Alzheimer's drug Leqembi could save Medicare hundreds of millions ...
A simple tweak in available vial sizes of the breakthrough Alzheimer's drug Leqembi could save Medicare hundreds of millions ...
Medicare could save millions of dollars every year by changing the way they package Alzheimer's medication.
A recent study supported by the National Institutes of Health (NIH) and published in Nature Neuroscience found that Alzheimer ...
Gene therapy could help obese kids avoid health problems associated with excess weight, including arthritis, a new study ...
New research suggests that Medicare could save up to 74 percent of the money lost from discarded Alzheimer's drug Leqembi or ...
A man from Kerala experienced severe body pain and fatigue upon seeking medical attention, he was diagnosed with rare ...
Medpage Today on MSN23h
Alzheimer's Drug in Smaller Vial Sizes Could Save Medicare Hundreds of MillionsAn estimated $133 million to $336 million worth of lecanemab may be discarded every year. Adding a 75-mg vial could save ...
The biotechnology industry is rapidly evolving, with innovative companies pushing the boundaries of science and medicine. To ...
Lecanemab (Leqembi; Eisai/Biogen) received traditional approval from the FDA in July 2023, following an accelerated approval ...
Biogen (BIIB – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Mohit Bansal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback